1-SUBSTITUTED-3-(NAPHTHALEN-1-YLSULFONYL)-5-(PIPERAZIN-1-YL)-1H-INDAZOLE COMPOUNDS AS 5-HYDROXYTRYPTAMINE-6 LIGANDS
申请人:Liu Kevin Guangcheng
公开号:US20090318470A1
公开(公告)日:2009-12-24
The disclosure is directed to compounds of Formula I:
processes for their preparation, treatment of central nervous system (CNS) disorders and methods for the modulation of 5HT
6
activity.